e-learning
resources
Copenhagen 2005
Wednesday 21.09.2005
The injured lung: pathogenesis and interventions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Electroporation mediated gene transfer of hepatocyte growth factor reduces bleomycin induced pulmonary fibrosis
A. Gazdhar, P. Fachinger, C. VanLeer, J. Pierog, M. Gugger, S. Hyde, R. Schmid, T. Geiser (Bern, Switzerland; Oxford, United Kingdom)
Source:
Annual Congress 2005 - The injured lung: pathogenesis and interventions
Session:
The injured lung: pathogenesis and interventions
Session type:
Poster Discussion
Number:
4643
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Gazdhar, P. Fachinger, C. VanLeer, J. Pierog, M. Gugger, S. Hyde, R. Schmid, T. Geiser (Bern, Switzerland; Oxford, United Kingdom). Electroporation mediated gene transfer of hepatocyte growth factor reduces bleomycin induced pulmonary fibrosis. Eur Respir J 2005; 26: Suppl. 49, 4643
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Lipoid pneumonia in infants: treatment with multiple bronchoalveolar lavages
Related content which might interest you:
Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Pleural fibrosis induced by transforming growth factor (TGF)-β1 gene transfer
Source: Eur Respir J 2005; 26: Suppl. 49, 100s
Year: 2005
Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice.
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003
Attenuation of bleomycin-induced pulmonary fibrosis by direct thrombin inhibition is accompanied by a reduction in connective tissue growth factor mRNA levels
Source: Eur Respir J 2001; 18: Suppl. 33, 199s
Year: 2001
Gp130-Stat3 signalling regulates sensitivity to bleomycin induced lung fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 604s
Year: 2006
Tankyrase(TNKS) inhibiting autophagy promotes the TGF-ß induced EMT process in vitro and Bleomycin(BLM) induced pulmonary fibrosis in rats
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
Keratinocyte growth factor (rHuKGF) increases surfactant protein A in rats and prevents alveolar oedema after orthotopic rat lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 779s
Year: 2006
Electroporation-mediated HGF gene transfer increases mesenchymal stem cell and decreases MMP24 levels in a bleomycin-induced lung injury model.
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction
Source: Eur Respir J 2012; 40: 424-435
Year: 2012
c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
The effects of erdosteine and N-acetylcysteine treatment following lung injury on the regulation of apoptosis of capillary endothelial cells in the model of experimental pulmonary fibrosis induced by bleomycin
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
PTEN reduces vascular endothelial growth factor–mediated vascular permeability in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 581s
Year: 2005
Follistatin-like 1 promotes intermittent hypoxia-induced lung fibroblast activation in vitro and in vivo
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Modulation of fibroblast phenotype in idiopathic pulmonary fibrosis: Role of Nrf2
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
RB2/p130 gene-enhanced expression downregulates vascular endothelial growth factor expression and inhibits angiogenesis
in vivo
Source: Eur Respir J 2002; 20: Suppl. 38, 3s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept